Agenzia Italiana del Farmaco
Direct communication with healthcare professionals on Spikevax bivalent booster vaccines - Direct communication with healthcare professionals on Spikevax bivalent booster vaccines
Direct communication with healthcare professionals on Spikevax bivalent booster vaccines
The Italian Medicines Agency would like to inform you of the following:
Reports of accidental underdosing of the Spikevax bivalent booster vaccines have been reported, where a 0.25 mL dose (equivalent to 25 µg) was administered instead of 0.5 mL (50 µg). In most cases, underdosing was due to dose confusion, since the booster dose volume for the original monovalent Spikevax vaccine used earlier in 2022 was 0.25 mL (equivalent to 50 µg).
- Spikevax bivalent booster vaccines have recently been approved by EMA for use in individuals 12 years of age and older. The correct dose is 0.5 mL (50 µg).
Published on: 11 November 2022
👥💬 Parte “AIFA Ascolta”, uno spazio di dialogo con associazioni, reti e federazioni dei #pazienti,...
Vai al post →
📣 Unisciti a noi contro l'antibiotico-resistenza!
💊 Utilizza gli #antibiotici in modo consapevole ...
Vai al post →
💙 18 novembre – Giornata Europea per l’uso consapevole degli #antibiotici
#AIFA si illumina di blu...
Vai al post →
📅 Giornata europea e Settimana Mondiale per l’uso consapevole degli antibiotici
"Dalla resistenza ...
Vai al post →
📊 Presentato in #AIFA il Rapporto OsMed 2024 sull’uso dei #farmaci in Italia.
Dati principali ⬇️
?...
Vai al post →
Si conclude la campagna #MedSafetyWeek di quest’anno! 🎉
Grazie per aver seguito i nostri canali in ...
Vai al post →
